High lethality rate of carbapenem-resistant Acinetobacter baumannii in Intensive Care Units of a Brazilian hospital: An epidemiologic surveillance study
Rev. Soc. Bras. Med. Trop
; 55: e0529, 2022. tab, graf
Article
en En
|
LILACS-Express
| LILACS
| ID: biblio-1376339
Biblioteca responsable:
BR1.1
ABSTRACT
ABSTRACT Background:
Carbapenem-resistant Acinetobacter baumannii (CRAB) is a growing threat to public health.Methods:
A 3-year retrospective study was conducted to evaluate the prevalence and lethality of multidrug-resistant (MDR) A. baumannii isolated from Brazilian patients.Results:
In this study, 219 Acinetobacter baumannii isolates were identified, of which 70.8% (155/219) were isolated from patients hospitalized in intensive care units. Of these, 57.4% (n = 89/155) were assessed, of which 92.1% (82/89) were carbapenem-resistant, and 49 were classified as infected. The lethality rate was 79.6% (39/49).Conclusions:
We highlight the need of an effective epidemiological surveillance measure to contain the dissemination of CRAB in the hospital environment.
Texto completo:
1
Índice:
LILACS
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
/
Screening_studies
País/Región como asunto:
America do sul
/
Brasil
Idioma:
En
Revista:
Rev. Soc. Bras. Med. Trop
Asunto de la revista:
MEDICINA TROPICAL
Año:
2022
Tipo del documento:
Article